Associated Papers
ATR&RNASEL germline variants: novel findings in a case of familial cancer.
Biswas S et al.
Molecular Genetics and Genomics : Mgg, 2025
Non-truncating BMPR1A variants associated with familial colorectal cancer and adenomatous polyps.
Nieminen TT et al.
Bmc Cancer, 2025
Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma.
Öfverholm I et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2024
Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children.
Lee D et al.
Science (new York, N.y.), 2023
Prognostic role of genetic biomarkers in clinical progression of prostate cancer.
Alvarez-Cubero MJ et al.
Experimental & Molecular Medicine, 2015
Functional and Structural Consequences of Damaging Single Nucleotide Polymorphisms in Human Prostate Cancer Predisposition Gene RNASEL.
Datta A et al.
Biomed Research International, 2015
Predictive value in the analysis of RNASEL genotypes in relation to prostate cancer.
Alvarez-Cubero MJ et al.
Prostate Cancer and Prostatic Diseases, 2012
Genetic variation in RNASEL and risk for prostate cancer in a population-based case-control study.
Fesinmeyer MD et al.
The Prostate, 2011
Genome-wide analysis to predict protein sequence variations that change phosphorylation sites or their corresponding kinases.
Ryu GM et al.
Nucleic Acids Research, 2009
Germline mutation in RNASEL predicts increased risk of head and neck, uterine cervix and breast cancer.
Madsen BE et al.
Plos One, 2008
RNASEL gene polymorphisms and the risk of prostate cancer: a meta-analysis.
Li H et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2006
Mutational analysis of susceptibility genes RNASEL/HPC1, ELAC2/HPC2, and MSR1 in sporadic prostate cancer.
Nupponen NN et al.
Genes, Chromosomes & Cancer, 2004
Implications for RNase L in prostate cancer biology.
Silverman RH
Biochemistry, 2003
Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer.
Rökman A et al.
American Journal of Human Genetics, 2002
Patient-derived glioblastoma organoids reflect tumor heterogeneity and treatment sensitivity.
Verduin M et al.
Neuro-oncology Advances, 0